Drugs / Avagard
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | AVAGARD | — | 2001-06-07 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00731042 | Mar → Apr 2008 | — | Solventum US LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Avagard | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00731042 ↗ |
| Route | Topical | “Topical solution” NCT00731042 ↗ |